OOIR: Observatory of International Research

Papers

(The TQCC of Journal of the Peripheral Nervous System is 4. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)

Article	Citations
	69
	31
Broadening Research Priorities in Peripheral Neuropathy: A Response to “A Call to Action for Peripheral Neuropathy Research Funding—Time to Consolidate Funding Under One NIH Initiative?”	30
Safety and Cost Analysis of Immunoglobulin Cessation Trials in Chronic Inflammatory Demyelinating Polyradiculoneuropathy	29
PNS Abstracts 2023	24
Prospective Evaluation of Machine‐Assisted Electrophysiologic and Online Clinical Diagnostic Support Tools in Chronic Inflammatory Demyelinating Polyradiculoneuropathy	21
Abstracts	21
Identifying Predictors of Idiopathic Small‐Fiber Neuropathy in Adolescent Patients With Chronic Pain	21
	21
Toxic medications in Charcot–Marie–Tooth patients: A systematic review	21
Incidence and risk factors for developing chemotherapy‐induced neuropathic pain in 500 cancer patients: A file‐based observational study	20
Abstracts of the 33rd annual meeting of the Japanese peripheral nerve society (JPNS)	20
Nerve ultrasound as a screening tool for inherited sensory neuronopathy	18
Issue Information	18
Loss of MEGF10 Decreases the Number of Perisynaptic Schwann Cells and Innervation of Neuromuscular Junctions in Aging Mice	16
Ofatumumab for treating autoimmune nodopathy	15
Genetic, electrophysiological, and pathological studies on patients with SCN9A‐related pain disorders	15
Variability in Conduction Block Definitions Affects the Sensitivity of Diagnostic Criteria for Multifocal Motor Neuropathy	14
Broadening the Clinical Spectrum of Axonal Hereditary Neuropathies: A Comparative Case Study on DNAJB2‐ and HINT1‐	14
Corneal confocal microscopy in small and mixed fiber neuropathy—Comparison with skin biopsy and cold detection in a large prospective cohort	14
Abstracts of the 35th Annual Meeting of the Japanese Peripheral Nerve Society (JPNS)	13
Assessing corneal dendritic cells in glucose dysregulation small‐fibre neuropathy	13
Effectiveness of exercise therapy for individuals diagnosed with Charcot–Marie–Tooth disease: A systematic review of randomized clinical trials	13
Feasibility, Validity, and Reliability of the Virtual CMT Infant Toddler Scale (vCMTInfS): A Remote Evaluation of Infants/Toddlers With CMT	13
Issue Information	13

Conduction slowing, conduction block and temporal dispersion in demyelinating, dysmyelinating and axonal neuropathies: Electrophysiology meets pathology	13
Behavioral Thermoceptive Responses and Morphologic Correlates in Mouse Models of CMT1A , HNPP , an	12
Association of dynamic hepatic metabolism with clinical outcomes in patients with severe Guillain‐Barré syndrome: A prospective cohort study from multi‐centers in China	12
Issue Information	12
Novel Dominant Splicing Variant in MPZ Associated With Unusual Charcot–Marie–Tooth Disease	11
Chronic inflammatory demyelinating polyradiculoneuropathy: Diagnostic problems in clinical practice in Serbia	11
Issue Information	11
Parent‐proxy pediatric CMT quality of life outcome measure: Validation of the Italian version	11
A Novel Case of Nerve Biopsy Proven Wild Type Transthyretin (TTR) Amyloidosis	11
IgM anti‐MAG^± peripheral neuropathy (IMAGiNe) study protocol: An international, observational, prospective registry of patients with IgM M‐protei	11
Pain hypersensitivity, sensorimotor impairment, and decreased muscle force in a novel rat model of radiation‐induced peripheral neuropathy	11
Cranial Nerve Involvement With Diplopia as Presenting Feature of CMT1H Caused by Recurring FBLN5 Varia	11
Diagnostic and clinical utility of comprehensive multigene panel testing for patients with neuropathy	10
Rethinking Neuropathy in TTC19 Mutations: The Need for Broader Differential Diagnosis	10
Disease‐specific wearable sensor algorithms for profiling activity, gait, and balance in individuals with Charcot–Marie–Tooth disease type 1A	10
Peter James Dyck: In Memoriam	9
Peripheral neuropathy as clinical onset of monoclonal IgM/k‐related amyloidosis	9
Patient‐reported disease burden in the Accelerate Clinical Trials in Charcot–Marie–Tooth Disease Study	9
Benefit of high‐dose oral riboflavin therapy in riboflavin transporter deficiency	9
Frequent De Novo Mutations in Korean Patients With Charcot–Marie–Tooth Disease	9
Unveiling a Regional Variant of Demyelinating Guillain–Barré Syndrome: Nerve Conduction Study Evidence in Bifacial Weakness With Paresthesias	9
Issue Information	8
Issue Information	8
	8
	8
Glucose‐lowering medication associated with weight loss may limit the progression of diabetic neuropathy in type 2 diabetes	7
Intravenous Immunoglobulin Elevates Regulatory T Cells in Guillain‐Barré Syndrome: A Potential Biomarker of Therapeutic Response	7
Issue Information	7
Dapagliflozin for Small Nerve Fibre Regeneration in Diabetic Peripheral Neuropathy: A Randomised Controlled Study (DINE)	7
Issue Information	6
ABSTRACT	6
Molecular Characterization of Oxaliplatin‐Induced Peripheral Neurotoxicity: The Complex Spectrum of Painful Manifestations	6
Correction to “Polyneuropathy in Kidney Transplant Recipients: Accuracy of a New Clinical Diagnostic Scoring System”	6
	6
A novel de novo variant in POLR3B gene associated with a primary axonal involvement of the largest nerve fibers	6
Reply to “Nerve ultrasound as a screening tool for inherited sensory neuronopathy”	6
The autoimmune vulnerability of the node of Ranvier	6
Clinical and genetic features of CMT2T in Italian patients confirm the importance of MME pathogenic variants in idiopathic, late‐onset axonal neuropathies	6
Measurement of Red Blood Cell Sorbitol Dehydrogenase Activity for Fast Screening of SORD ‐Related Neuropathies	6
An innovative phase 2 proof‐of‐concept trial design to evaluate SAR445088, a monoclonal antibody targeting complement C1s in chronic inflammatory demyelinating polyneuropathy	6
	6
Validation of an Artificial Intelligence driven framework to automatically detect red flag symptoms in screening for rare diseases in electronic health records: hereditary transthyretin amyloidosis po	6
	6
Overall Diagnostic Performance of Multiple Versus Single Physical Examination Tests for the Prediction of Future Diabetic Neuropathy Risk	6
Assessing deterioration using impairment and functional outcome measures in chronic inflammatory demyelinating polyneuropathy: A post‐hoc analysis of the immunoglobulin overtreatment in CIDP trial	5
Do corticosteroids aggravate pure motor chronic inflammatory demyelinating polyneuropathy?	5
Acquired Transthyretin Amyloidosis in Domino Liver Transplantation Treated With Gene‐Silencers	5
Impact of High‐Dose Tafamidis on Hereditary ATTR ( ATTRv ) Amyloidosis With Central Nervous System	5
Diagnostic value of nerve conduction study in NOTCH2NLC‐related neuronal intranuclear inclusion disease	5
High‐Fat Diet Disrupt Nerve Function by Targeting Schwann Cells	5

Automated immunohistochemistry of intra‐epidermal nerve fibres in skin biopsies: A proof‐of‐concept study	5
INF2 mutations in patients with a broad phenotypic spectrum of Charcot‐Marie‐Tooth disease and focal segmental glomerulosclerosis	5
Influence of Genomic Ancestry and Other Traditional Risk Factors on the Prevalence of Diabetic Peripheral Neuropathy in Admixed Individuals With Type 1 Diabetes in Brazil: A Pioneer Multicenter Study	5
The small fiber neuropathy—symptom inventory questionnaire (SFN‐SIQ) does not discriminate between patients with or without small fiber neuropathy	5
GDAP1‐Related Charcot–Marie–Tooth Disease: Axonal or Demyelinating Subtype? Autosomal Recessive or Autosomal Dominant Inheritance?	5
Nonsystemic Vasculitic Neuropathy—A Brazilian Case Series	5
Digenesis in Charcot–Marie–Tooth Disease: Impact of Combined Mutations in the MFN2 and GDAP1 Genes	5
Serum neurofilament light chain as a reliable biomarker of hereditary transthyretin‐related amyloidosis—A Swiss reference center experience	5
Issue Information	5
Elucidating Causal Associations Between Immune Cells, Circulating Inflammatory Proteins, and Chronic Inflammatory Demyelinating Polyneuropathy: A Two‐Sample Two‐Step Mendelian Randomization Study	4
SOX5 Overexpression in Schwann Cell Combined With Chitosan‐Based Conduit Promotes Peripheral Nerve Regeneration	4
Clinical and Electrophysiological Characterization of Diabetic Neuropathy in a Sub‐Saharan African Cohort	4
Rasch‐Built Overall Disability Scale for IgM‐Associated Polyneuropathy With and Without Anti‐MAG Antibodies: IgM‐RODS	4
Cytokines and chemokines in patients with chronic inflammatory demyelinating polyradiculoneuropathy and multifocal motor neuropathy: A systematic review	4
A Case of Retinopathy–Sensory Neuropathy Syndrome With a Novel Compound Heterozygous FLVCR1 Varian	4
Earlier diagnosis of peripheral neuropathy in primary care: A call to action	4
A New Simple SCreening Tool for Painful Diabetic Neuropathy ( ACT ) in Ecuador	4
Genetic and Clinical Features of 10 Families With Hereditary Sensory Neuropathies	4
Recent advances in the treatment of Charcot‐Marie‐Tooth neuropathies	4
Anxiety and depression in small fiber neuropathy	4
Macrophages influence Schwann cell myelin autophagy after nerve injury and in a model of Charcot‐Marie‐Tooth disease	4
Pathological Features of Vasculitic Neuropathy and the Role of Nerve Biopsy	4
Issue Information	4
Genetic and clinical profile of 15 Chinese families with GDAP1‐related Charcot–Marie–Tooth disease and identification of H256R as a frequent mutation	4
Phenotypic features of RETREG1‐related hereditary sensory autonomic neuropathy	4
Cutaneous biomarkers of therapeutic efficacy in early treatment of hereditary ATTR amyloid polyneuropathy with tafamidis	4
The diagnostic accuracy of the small fiber neuropathy symptoms inventory questionnaire (SFN‐SIQ): Reply to letter to the Editor	4